Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACAD | AMGN | GILD | CELG | VRTX |
| Company | Acadia Pharmaceutica | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 16.98 | 264.63 | 66.25 | 108.01 | 394.72 |
| High | 17.30 | 269.38 | 66.83 | 108.59 | 396.98 |
| Low | 16.62 | 260.68 | 66.16 | 107.27 | 391.25 |
| Last | 16.82 | 268.93 | 66.76 | 108.24 | 394.28 |
| Change | -0.25 | +6.18 | +0.60 | +0.11 | +0.80 |
| % Change | -1.46% | +2.35% | +0.91% | +0.10% | +0.20% |
| Volume | 3,628,000 | 3,380,300 | 10,656,899 | 191,230,496 | 1,342,100 |
| 20-Day Average Volume | 1,467,260 | 2,246,435 | 6,455,915 | 16,188,930 | 931,825 |
| Previous Close | 17.07 | 262.75 | 66.16 | 108.13 | 393.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 17.72 | 272.56 | 69.90 | 108.17 | 405.52 |
| 20-Day Raw Stochastic | 10.84% | 29.59% | 10.79% | 63.25% | 10.74% |
| 20-Day Relative Strength | 29.95% | 43.95% | 31.30% | 64.69% | 37.76% |
| Weighted Alpha | -43.82 | +7.67 | -24.32 | +46.30 | +15.95 |
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 72% Sell | 8% Sell | 72% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.87% since 04/12/24 | +0.62% since 04/12/24 | -1.92% since 04/12/24 | -1.97% since 11/13/19 | -0.57% since 04/12/24 |
| Low | 16.60 on 04/16/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 391.01 on 04/18/24 |
| High | 17.35 on 04/18/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 110.53 on 11/14/19 | 402.49 on 04/15/24 |
| 1-Month | |||||
| %Chg | -10.05% since 03/19/24 | -1.03% since 03/19/24 | -9.06% since 03/19/24 | +5.14% since 10/18/19 | -5.04% since 03/19/24 |
| Low | 16.60 on 04/16/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 19.00 on 03/21/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -38.37% since 01/19/24 | -12.63% since 01/19/24 | -23.52% since 01/19/24 | +13.63% since 08/20/19 | -9.37% since 01/19/24 |
| Low | 16.60 on 04/16/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 29.29 on 01/24/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -26.65% since 10/19/23 | -4.16% since 10/19/23 | -14.89% since 10/19/23 | +14.14% since 05/20/19 | +8.08% since 10/19/23 |
| Low | 16.60 on 04/16/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 32.59 on 12/22/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,812,658 | 140,812,720 | 82,374,304 | 77,035,920 | 101,698,464 |
| Shares Outstanding, K | 164,772 | 535,919 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 726,440,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -61,290,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 231,040,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 45,800,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 0.37 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.28 on 02/27/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 10.99 | 29.25 |